Business Description
Appili Therapeutics is a Canadian company founded in 2015 and based in Halifax, focused on finding and developing new treatments for infectious diseases that currently lack good options. Its pipeline includes three key products: a child-friendly liquid form of the antibiotic metronidazole, a topical treatment for a parasitic skin disease called cutaneous leishmaniasis, and a vaccine targeting a rare but dangerous bacterial infection known as tularemia.
